Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
How Can Digital Health Transform Disease Surveillance in Africa?
Digital Health How Can Digital Health Transform Disease Surveillance in Africa?

Imagine a remote village in Sub-Saharan Africa where a sudden fever outbreak goes unnoticed for weeks, silently spreading to neighboring communities because health workers rely on paper reports that take days to reach national authorities. This scenario, far too common across the continent,

Custom Roof Hatch Secures Gamma Knife at Ochsner Medical
Infrastructure & Management Custom Roof Hatch Secures Gamma Knife at Ochsner Medical

Imagine a scenario where a $7 million piece of life-saving medical equipment, weighing a staggering 21 tons, needs to be carefully lowered into a mid-20th-century building during a major renovation, all while ensuring its protection from weather and unauthorized access for years to come. This was

How Is Xeltis Revolutionizing Vascular Implants with €47.5M?
Infrastructure & Management How Is Xeltis Revolutionizing Vascular Implants with €47.5M?

Imagine a world where vascular implants don’t just act as temporary fixes but actually help the body heal itself, transforming into natural tissue over time. This vision is becoming reality thanks to Xeltis, a Netherlands-based medical technology innovator that recently secured an impressive €47.5

Tampa General Hospital Boosts Efficiency with AI Voice Agents
Digital Health Tampa General Hospital Boosts Efficiency with AI Voice Agents

Imagine a hospital call center so swamped that one in three callers hangs up before ever speaking to someone, while those who wait endure minutes that feel like hours, all just to book a simple appointment. This was the reality for Tampa General Hospital (TGH), a leading not-for-profit academic

Why Choose TruHealth GLP-1 Ready for Therapy Safety?
Imaging & Diagnostics Why Choose TruHealth GLP-1 Ready for Therapy Safety?

Imagine stepping into a new chapter of health management with GLP-1 receptor agonist therapy, a promising approach for tackling type 2 diabetes or weight issues, only to face unexpected risks due to unseen health conditions. This scenario is far too common for many patients who dive into treatment

Can Medicare’s 2027 Drug Deals Save $12B—And What’s Next?
Regulatory & Compliance Can Medicare’s 2027 Drug Deals Save $12B—And What’s Next?

The IRA’s negotiation era comes into focus: why the 2027 price list matters now Sudden, double-digit cuts to high-spend drugs concentrate attention fast, and the newly finalized 2027 Medicare prices did exactly that by signaling roughly $12 billion in backcast savings if applied to 2024 use and an

SimonMed Launches AI Platform to Boost Mammogram Follow-Ups
Imaging & Diagnostics SimonMed Launches AI Platform to Boost Mammogram Follow-Ups

When a mammogram flags a concern, the clock starts ticking on follow-up care that too often stalls in confusion, voicemail loops, and missed appointments that undermine early detection. That gap—by SimonMed’s estimate, missed by up to 30% of eligible patients—has become the target of a new

mHealth Cuts Burden, Builds Coping for Cancer Caregivers
Digital Health mHealth Cuts Burden, Builds Coping for Cancer Caregivers

Caregivers of older adults with cancer confront a moving target of medical tasks and emotional strains that rarely pause long enough for traditional support to keep pace, and the gap between what families must do and the help they receive has real consequences for patient stability and caregiver

Are We Aligning Policy on Obesity, Diet, and Imaging?
Imaging & Diagnostics Are We Aligning Policy on Obesity, Diet, and Imaging?

Across boardrooms, journals, and committee rooms, a quiet realignment has been reshaping how the country thinks about obesity, diet quality, and diagnostic imaging as interlocking levers of population health rather than siloed issues with fragmented fixes. The latest signals came from three fronts:

How Will CMS Telehealth Updates Impact Providers and Patients?
Digital Health How Will CMS Telehealth Updates Impact Providers and Patients?

In the wake of a significant 43-day government shutdown, telehealth services under Medicare faced unprecedented disruptions, leaving providers unpaid and patients grappling with access issues, sparking intense discussion among healthcare stakeholders about the sustainability of virtual care. With

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later